Ralph A. Stearns

4.3k total citations
68 papers, 2.5k citations indexed

About

Ralph A. Stearns is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Ralph A. Stearns has authored 68 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pharmacology, 21 papers in Molecular Biology and 17 papers in Pharmacology. Recurrent topics in Ralph A. Stearns's work include Pharmacogenetics and Drug Metabolism (27 papers), Drug Transport and Resistance Mechanisms (13 papers) and Inflammatory mediators and NSAID effects (12 papers). Ralph A. Stearns is often cited by papers focused on Pharmacogenetics and Drug Metabolism (27 papers), Drug Transport and Resistance Mechanisms (13 papers) and Inflammatory mediators and NSAID effects (12 papers). Ralph A. Stearns collaborates with scholars based in United States, Japan and Canada. Ralph A. Stearns's co-authors include Wei Tang, Thomas A. Baillie, Paul R. Ortiz de Montellano, George A. Doss, Probir Chakravarty, Shuet-Hing Lee Chiu, Regina W. Wang, Randall R. Miller, S H Chiu and David C. Evans and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Agricultural and Food Chemistry.

In The Last Decade

Ralph A. Stearns

68 papers receiving 2.4k citations

Peers

Countries citing papers authored by Ralph A. Stearns

Since Specialization

Citations

This map shows the geographic impact of Ralph A. Stearns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph A. Stearns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph A. Stearns more than expected).

Fields of papers citing papers by Ralph A. Stearns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph A. Stearns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph A. Stearns. The network helps show where Ralph A. Stearns may publish in the future.

Co-authorship network of co-authors of Ralph A. Stearns

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph A. Stearns. A scholar is included among the top collaborators of Ralph A. Stearns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph A. Stearns. Ralph A. Stearns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Vitro Metabolic Activation of Lumiracoxib in Rat and Human Liver Preparations 2007 ·Drug Metabolism and Disposition ·Ying Li, J. Greg Slatter, Zhoupeng Zhang, Yan Li, George A. Doss, Matthew P. Braun, Ralph A. Stearns, Dennis Dean, Thomas A. Baillie, Wei Tang	34
2	Influence of different recombinant systems on the cooperativity exhibited by cytochrome P4503A4 2004 ·Xenobiotica ·(unknown), (unknown), Magang Shou, (unknown), Jason S. Ngui, Ralph A. Stearns, David C. Evans, Thomas A. Baillie, Wei Tang	15
3	IDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENT 2004 ·Drug Metabolism and Disposition ·Randall R. Miller, George A. Doss, Ralph A. Stearns	14
4	Effect of Quinidine on the 10-Hydroxylation of R-Warfarin: Species Differences and Clearance Projection 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Qing Chen, Eugene Tan, John R. Strauss, Zhoupeng Zhang, Judith E. Fenyk-Melody, Catherine Booth-Genthe, Thomas H. Rushmore, Ralph A. Stearns, David C. Evans, Thomas A. Baillie, Wei Tang	2
5	Amidines as amide bond replacements in VLA-4 antagonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Theodore M. Kamenecka, (unknown), Linus S. Lin, (unknown), Ermengilda McCauley, Gail Van Riper, Linda A. Egger, (unknown), Richard A. Mumford, Sharon Tong, Wei Tang, Adria Colletti, Yohannes Teffera, Ralph A. Stearns, Malcolm MacCoss, John A. Schmidt, William K. Hagmann	15
6	Addressing the metabolic activation potential of new leads in drug discovery: a case study using ion trap mass spectrometry and tritium labeling techniques 2003 ·Journal of Mass Spectrometry ·Koppara Samuel, (unknown), Ralph A. Stearns, Yui S. Tang, Ashok Chaudhary, James P. Jewell, Thomas J. Lanza, Linus S. Lin, William K. Hagmann, David C. Evans, Sanjeev Kumar	53
7	Metabolism of a Thiazole Benzenesulfonamide Derivative, a Potent and Selective Agonist of the Human β3-Adrenergic Receptor, in Rats: Identification of a Novel Isethionic Acid Conjugate 2002 ·Drug Metabolism and Disposition ·Wei Tang, Ralph A. Stearns, Randall R. Miller, Jason S. Ngui, Robert J. Mathvink, Ann E. Weber, Gloria Y. Kwei, John R. Strauss, Carol Keohane, George A. Doss, Shuet-Hing Lee Chiu, Thomas A. Baillie	8
8	Extrapolation of Diclofenac Clearance from in Vitro Microsomal Metabolism Data: Role of Acyl Glucuronidation and Sequential Oxidative Metabolism of the Acyl Glucuronide 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Sanjeev Kumar, Koppara Samuel, S. Ramaswamy, Matthew P. Braun, Ralph A. Stearns, Shuet-Hing Lee Chiu, David C. Evans, Thomas A. Baillie	138
9	The Pharmacokinetics of a Thiazole Benzenesulfonamide β3-Adrenergic Receptor Agonist and Its Analogs in Rats, Dogs, and Monkeys: Improving Oral Bioavailability 2002 ·Drug Metabolism and Disposition ·Ralph A. Stearns, Randy R. Miller, Wei Tang, Gloria Y. Kwei, (unknown), Robert J. Mathvink, Elizabeth M. Naylor, (unknown), Vincent J. Colandrea, Ann E. Weber, Adria Colletti, John R. Strauss, Carol Keohane, William P. Feeney, Susan A. Iliff, Shuet‐Hing Lee Chiu	8
10	Design and biological profile for selective agonists for the melanocortin subtype-4 receptor 2001 ·Ravi P. Nargund, Iyassu K. Sebhat, (unknown), Khaled Barakat, David H. Weinberg, Tanya MacNeil, Rubana N. Kalyani, William J. Martin, Doreen E. Cashen, (unknown), Jennifer E. Drisko, Ralph Mosley, Tung M. Fong, Ralph A. Stearns, Randy R. Miller, (unknown), Lawrence F. Colwell	1
11	Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective β3 adrenergic receptor agonist antiobesity agents 2000 ·Bioorganic & Medicinal Chemistry Letters ·Tesfaye Biftu, Dennis Feng, Gui‐Bai Liang, (unknown), Xiaoxia Qian, Elizabeth M. Naylor, Vincent J. Colandrea, Mari R. Candelore, Margaret A. Cascieri, Lawrence F. Colwell, Michael J. Forrest, Gary J. Hom, D. Euan MacIntyre, Ralph A. Stearns, Catherine D. Strader, Matthew J. Wyvratt, Michael H. Fisher, Ann E. Weber	17
12	Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist 2000 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Tesfaye Biftu, Mari R. Candelore, Margaret A. Cascieri, Lawrence F. Colwell, Liping Deng, William P. Feeney, Michael J. Forrest, Gary J. Hom, D. Euan MacIntyre, Randall R. Miller, Ralph A. Stearns, Catherine D. Strader, Laurie Tota, Matthew J. Wyvratt, Michael H. Fisher, Ann E. Weber	15
13	L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability 1999 ·Bioorganic & Medicinal Chemistry Letters ·Thomas L. Shih, Mari R. Candelore, Margaret A. Cascieri, Shuet‐Hing Lee Chiu, Lawrence F. Colwell, Liping Deng, William P. Feeney, Michael J. Forrest, Gary J. Hom, D. Euan MacIntyre, Randall R. Miller, Ralph A. Stearns, Catherine D. Strader, Laurie Tota, Matthew J. Wyvratt, Michael H. Fisher, Ann E. Weber	41
14	Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species. 1996 ·Drug Metabolism and Disposition ·Kwan Leung, Dosinda Cohn, Randall R. Miller, George A. Doss, Ralph A. Stearns, Richard E. Simpson, William P. Feeney, S H Chiu	8
15	Mechanism of bioactivation and covalent binding of 2,4,6-trinitrotoluene 1995 ·Chemico-Biological Interactions ·Kwan Leung, Yao Ming, Ralph A. Stearns, Shuet‐Hing Lee Chiu	62
16	Studies on non‐covalent associations of immunosuppressive drugs with serum albumin using pneumatically assisted electrospray ionization mass spectrometry 1995 ·Rapid Communications in Mass Spectrometry ·Ray Bakhtiar, Ralph A. Stearns	14
17	Formation of NADP(H) Analogs of Tobacco-Specific Nitrosamines in Rat Liver and Pancreatic Microsomes 1994 ·Chemical Research in Toxicology ·Lisa A. Peterson, Dennis K. P. Ng, Ralph A. Stearns, Stephen S. Hecht	19
18	In vivo covalent binding of [14C]trinitrotoluene to proteins in the rat 1992 ·Chemico-Biological Interactions ·Yuying Liu, Anthony Y.H. Lu, Ralph A. Stearns, Shuet‐Hing Lee Chiu	28
19	Radical Intermediates in the Cytochrome P-450-Catalyzed Oxidation of Aliphatic Hydrocarbons 1989 ·Drug Metabolism Reviews ·Paul R. Ortiz de Montellano, Ralph A. Stearns	9
20	The allylisopropylacetamide and novonal prosthetic heme adducts. 1984 ·Molecular Pharmacology ·P.R. Ortiz de Montellano, Ralph A. Stearns, Kevin C. Langry	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact